We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PCLOF market cap is 25.37M. The company's latest EPS is CAD -0.0858 and P/E is -1.75.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 1.54M | 2.65M | 1.94M | 5.31M |
| Operating Income | -144k | -22.97M | -35.54M | -22.39M | -12.01M |
| Net Income | -144k | -34.67M | -43.76M | -26.63M | -14.52M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 208k | 50.2M | 44.02M | 35.96M | 25.12M |
| Total Liabilities | 23k | 4.73M | 17.78M | 16.63M | 18.72M |
| Total Equity | 185k | 45.47M | 26.25M | 19.33M | 6.39M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -78k | -25.16M | -22.56M | -20.07M | -9.71M |
| Investing | N/A | -11.27M | -5.57M | -1.66M | -725k |
| Financing | 199k | 4.51M | 23.32M | 18.21M | 5.3M |
| Market Cap | 25.37M |
| Price to Earnings Ratio | -1.75 |
| Price to Sales Ratio | 4.78 |
| Price to Cash Ratio | 150 |
| Price to Book Ratio | 3.97 |
| Dividend Yield | - |
| Shares Outstanding | 169.14M |
| Average Volume (1 week) | 5.09k |
| Average Volume (1 Month) | 4.85k |
| 52 Week Change | -12.79% |
| 52 Week High | 0.22 |
| 52 Week Low | 0.07915 |
| Spread (Intraday) | 0.11 (49.23%) |
| Company Name | PharmaCielo Ltd (PK) |
| Address |
82 richmond street eas toronto, ontario M5C 1P1 |
| Website | https://www.pharmacielo.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
